593 filings
8-K
ELTP
Elite Pharmaceuticals Inc
14 Feb 24
Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024
4:55pm
10-Q
2024 Q3
ELTP
Elite Pharmaceuticals Inc
Quarterly report
14 Feb 24
4:06pm
8-K
ELTP
Elite Pharmaceuticals Inc
26 Dec 23
Regulation FD Disclosure
4:20pm
8-K
ELTP
Elite Pharmaceuticals Inc
12 Dec 23
Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR® to Marketing Partner Prasco, LLC
4:20pm
8-K
ELTP
Elite Pharmaceuticals Inc
14 Nov 23
Results of Operations and Financial Condition
5:22pm
8-K
wkd7gdiittz39myuxspx
25 Sep 23
Regulation FD Disclosure
4:15pm
8-K
alqf5wh
7 Sep 23
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
4:05pm
8-K
po2g7l54rj yj
14 Aug 23
Elite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024
5:30pm
8-K
kxkg7b9uk26e5nczkx
17 Jul 23
Changes in Registrant's Certifying Accountant
4:15pm
8-K
tw2kfx2 fjyf
29 Jun 23
Results of Operations and Financial Condition
5:15pm
8-K
5i4knj637hzc9ir1y
3 May 23
Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officer
4:15pm
8-K
zjkna1 mnt
20 Apr 23
Regulation FD Disclosure
10:05am
8-K
0h1 h0rcap2eh7d
28 Feb 23
Departure of Directors or Certain Officers
4:36pm
8-K
f1tjerw
14 Feb 23
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023
5:10pm
8-K
cax 3qz5su
22 Dec 22
Regulation FD Disclosure
4:21pm